Differential effects of early environmental enrichment on emotionality related behaviours in Huntington's disease transgenic mice

Journal of Physiology

Volumn 591, Issue 1, 2013, Pages 41-55

  Renoir, Thibault ^a   Pang, Terence Y C ^a   Mo, Christina ^a   Chan, Grace ^a   Chevarin, Caroline ^b,c   Lanfumey, Laurence ^b,c   Hannan, Anthony J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b INSERM   (France)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); SACCHARIN; SEROTONIN 1A RECEPTOR; SEROTONIN RECEPTOR; SULFUR 35;

ANHEDONIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; AVOIDANCE BEHAVIOR; BRAIN REGION; CONTROLLED STUDY; DEFECATION HABIT; DEPRESSION; DISEASE ASSOCIATION; DORSAL RAPHE NUCLEUS; EMOTIONALITY; ENDOPHENOTYPE; ENVIRONMENTAL ENRICHMENT; EXPLORATORY BEHAVIOR; FEEDING BEHAVIOR; FEMALE; FORCED SWIMMING TEST; GENE EXPRESSION; HIPPOCAMPUS; HUNTINGTON CHOREA; IMMOBILIZATION; IN VITRO STUDY; IN VIVO STUDY; MENTAL STRESS; MOUSE; NONHUMAN; POSTSYNAPTIC MEMBRANE; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; THERMOREGULATION; TRANSGENIC MOUSE; WILD TYPE;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; DEPRESSION; DISEASE MODELS, ANIMAL; EMOTIONS; ENVIRONMENT; FEMALE; HUNTINGTON DISEASE; HYPOTHERMIA; MICE; MICE, TRANSGENIC; SEROTONIN 5-HT1 RECEPTOR AGONISTS; STRESS, PSYCHOLOGICAL;

EID: 84872008712     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2012.239798     Document Type: Article

References (79)

1. Akimova E, Lanzenberger R & Kasper S (2009). The serotonin-1A receptor in anxiety disorders. Biol Psychiatry 66, 627-635.
2. Alt SR, Turner JD, Klok MD, Meijer OC, Lakke EA, Derijk RH & Muller CP (2010). Differential expression of glucocorticoid receptor transcripts in major depressive disorder is not epigenetically programmed. Psychoneuroendocrinology 35, 544-556.
3. Aziz NA, Pijl H, Frolich M, van der Graaf AW, Roelfsema F & Roos RA (2009). Increased hypothalamic-pituitary-adrenal axis activity in Huntington's disease. J Clin Endocrinol Metab 94, 1223-1228.
4. Bert B, Fink H, Hortnagl H, Veh RW, Davies B, Theuring F & Kusserow H (2006). Mice over-expressing the 5-HT(1A) receptor in cortex and dentate gyrus display exaggerated locomotor and hypothermic response to 8-OH-DPAT. Behav Brain Res 167, 328-341.
5. Bill DJ, Knight M, Forster EA & Fletcher A (1991). Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia. Br J Pharmacol 103, 1857-1864.
6. Bjorkqvist M, Petersen A, Bacos K, Isaacs J, Norlen P, Gil J, Popovic N, Sundler F, Bates GP, Tabrizi SJ, Brundin P & Mulder H (2006). Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease. Hum Mol Genet 15, 1713-1721.
7. Bouet V, Freret T, Dutar P, Billard JM & Boulouard M (2011). Continuous enriched environment improves learning and memory in adult NMRI mice through theta burst-related-LTP independent mechanisms but is not efficient in advanced aged animals. Mech Ageing Dev 132, 240-248.
8. Boulle F, Van Den Hove DL, Jakob SB, Rutten BP, Hamon M, van Os J, Lesch KP, Lanfumey L, Steinbusch HW & Kenis G (2012). Epigenetic regulation of the BDNF gene: implications for psychiatric disorders. Mol Psychiatry 17, 584-596.
9. Caliendo G, Santagada V, Perissutti E & Fiorino F (2005). Derivatives as 5HT1A receptor ligands-past and present. Curr Med Chem 12, 1721-1753.
10. Chandramohan Y, Droste SK, Arthur JS & Reul JM (2008). The forced swimming-induced behavioural immobility response involves histone H3 phospho-acetylation and c-Fos induction in dentate gyrus granule neurons via activation of the N-methyl-D-aspartate/extracellular signal-regulated kinase/mitogen- and stress-activated kinase signalling pathway. Eur J Neurosci 27, 2701-2713.
11. Chourbaji S, Brandwein C & Gass P (2011). Altering BDNF expression by genetics and/or environment: impact for emotional and depression-like behaviour in laboratory mice. Neurosci Biobehav Rev 35, 599-611.
12. Collins A, Hill LE, Chandramohan Y, Whitcomb D, Droste SK & Reul JM (2009). Exercise improves cognitive responses to psychological stress through enhancement of epigenetic mechanisms and gene expression in the dentate gyrus. PloS One 4, e4330.
13. D'Andrea I, Gracci F, Alleva E & Branchi I (2010). Early social enrichment provided by communal nest increases resilience to depression-like behaviour more in female than in male mice. Behav Brain Res 215, 71-76.
14. Dinan TG & Cryan JF (2012). Regulation of the stress response by the gut microbiota: Implications for psychoneuroendo-crinology. Psychoneuroendocrinology 37, 1369-1378.
15. Doyle JR & Yamamoto BK (2010). Serotonin 2 receptor modulation of hyperthermia, corticosterone, and hippocampal serotonin depletions following serial exposure to chronic stress and methamphetamine. Psychoneuroendocrinology 35, 629-633.
16. Du X, Leang L, Mustafa T, Renoir T, Pang TY & Hannan AJ (2012). Environmental enrichment rescues female-specific hyperactivity of the hypothalamic-pituitary-adrenal axis in a model of Huntington's disease. Transl Psychiatry 2, e133.
17. Duff K, Paulsen JS, Beglinger LJ, Langbehn DR & Stout JC (2007). Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study. Biol Psychiatry 62, 1341-1346.
18. Froger N, Palazzo E, Boni C, Hanoun N, Saurini F, Joubert C, Dutriez-Casteloot I, Enache M, Maccari S, Barden N, Cohen-Salmon C, Hamon M & Lanfumey L (2004). Neurochemical and behavioral alterations in glucocorticoid receptor-impaired transgenic mice after chronic mild stress. J Neurosci 24, 2787-2796.
19. Gorwood P (2008). Neurobiological mechanisms of anhedonia. Dialogues Clin Neurosci 10, 291-299.
20. Hamilton A & Holscher C (2012). The effect of ageing on neurogenesis and oxidative stress in the APP(swe)/PS1 (deltaE9) mouse model of Alzheimer's disease. Brain Res 1449, 83-93.
21. Hansson O, Guatteo E, Mercuri NB, Bernardi G, Li XJ, Castilho RF & Brundin P (2001). Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene. Eur J Neurosci 14, 1492-1504.
22. Harkin A, Houlihan DD & Kelly JP (2002). Reduction in preference for saccharin by repeated unpredictable stress in mice and its prevention by imipramine. J Psychopharmacol 16, 115-123.
23. Hedlund PB (2009). The 5-HT7 receptor and disorders of the nervous system: an overview. Psychopharmacology (Berl) 206, 345-354.
24. Hedlund PB, Kelly L, Mazur C, Lovenberg T, Sutcliffe JG & Bonaventure P (2004). 8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents. Eur J Pharmacol 487, 125-132.
25. Hensler J & Durgam H (2001). Regulation of 5-HT(1A) receptor-stimulated [35S]-GtpgammaS binding as measured by quantitative autoradiography following chronic agonist administration. Br J Pharmacol 132, 605-611.
26. Holl AK, Wilkinson L, Painold A, Holl EM & Bonelli RM (2010). Combating depression in Huntington's disease: effective antidepressive treatment with venlafaxine XR. Int Clin Psychopharmacol 25, 46-50.
27. Julien CL, Thompson JC, Wild S, Yardumian P, Snowden JS, Turner G & Craufurd D (2007). Psychiatric disorders in preclinical Huntington's disease. J Neurol Neurosurg Psychiatry 78, 939-943.
28. Kim HJ, Kim JY & Sun W (2012). Age-dependent changes in the subcallosal zone neurogenesis of mice. Neurochem Int (in press).
29. Kinn AM, Gronli J, Fiske E, Kuipers S, Ursin R, Murison R & Portas CM (2008). A double exposure to social defeat induces sub-chronic effects on sleep and open field behaviour in rats. Physiol Behav 95, 553-561.
30. Lanfumey L, Mongeau R, Cohen-Salmon C & Hamon M (2008). Corticosteroid-serotonin interactions in the neurobiological mechanisms of stress-related disorders. Neurosci Biobehav Rev 32, 1174-1184.
31. Laviola G, Hannan AJ, Macri S, Solinas M & Jaber M (2008). Effects of enriched environment on animal models of neurodegenerative diseases and psychiatric disorders. Neurobiol Dis 31, 159-168.
32. Laviola G, Rea M, Morley-Fletcher S, Di Carlo S, Bacosi A, De Simone R, Bertini M & Pacifici R (2004). Beneficial effects of enriched environment on adolescent rats from stressed pregnancies. Eur J Neurosci 20, 1655-1664.
33. Lazic SE, Grote HE, Blakemore C, Hannan AJ, van Dellen A, Phillips W & Barker RA (2006). Neurogenesis in the R6/1 transgenic mouse model of Huntington's disease: effects of environmental enrichment. Eur J Neurosci 23, 1829-1838.
34. Liu L, Li Q, Sapolsky R, Liao M, Mehta K, Bhargava A & Pasricha PJ (2011). Transient gastric irritation in the neonatal rats leads to changes in hypothalamic CRF expression, depression- and anxiety-like behaviour as adults. PloS One 6, e19498.
35. Liu X, Peprah D & Gershenfeld HK (2003). Tail-suspension induced hyperthermia: a new measure of stress reactivity. J Psychiatr Res 37, 249-259.
36. Llorens-Martin M, Tejeda GS & Trejo JL (2010). Differential regulation of the variations induced by environmental richness in adult neurogenesis as a function of time: a dual birthdating analysis. PLoS One 5, e12188.
37. Llorens-Martin MV, Rueda N, Martinez-Cue C, Torres-Aleman I, Florez J & Trejo JL (2007). Both increases in immature dentate neuron number and decreases of immobility time in the forced swim test occurred in parallel after environmental enrichment of mice. Neuroscience 147, 631-638.
38. Maes M, Kubera M, Obuchowiczwa E, Goehler L & Brzeszcz J (2011). Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways. Neuroendocrinol Lett 32, 7-24.
39. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW & Bates GP (1996). Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493-506.
40. Marshall J, White K, Weaver M, Flury Wetherill L, Hui S, Stout JC, Johnson SA, Beristain X, Gray J, Wojcieszek J & Foroud T (2007). Specific psychiatric manifestations among preclinical Huntington disease mutation carriers. Arch Neurol 64, 116-121.
41. Martinowich K, Manji H & Lu B (2007). New insights into BDNF function in depression and anxiety. Nat Neurosci 10, 1089-1093.
42. McGowan PO, Sasaki A, D'Alessio AC, Dymov S, Labonte B, Szyf M, Turecki G & Meaney MJ (2009). Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 12, 342-348.
43. Melas PA, Rogdaki M, Lennartsson A, Bjork K, Qi H, Witasp A, Werme M, Wegener G, Mathe AA, Svenningsson P & Lavebratt C (2012). Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression. Int J Neuropsychopharmacol 15, 669-679.
44. Meller E, Li H, Carr KD & Hiller JM (2000). 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency. J Pharmacol Exp Ther 292, 684-691.
45. Moncek F, Duncko R, Johansson BB & Jezova D (2004). Effect of environmental enrichment on stress related systems in rats. J Neuroendocrinol 16, 423-431.
46. Morley-Fletcher S, Rea M, Maccari S & Laviola G (2003). Environmental enrichment during adolescence reverses the effects of prenatal stress on play behaviour and HPA axis reactivity in rats. Eur J Neurosci 18, 3367-3374.
47. Morrison SF & Nakamura K (2011). Central neural pathways for thermoregulation. Front Biosci 16, 74-104.
48. Nestler EJ & Hyman SE (2010). Animal models of neuropsychiatric disorders. Nat Neurosci 13, 1161-1169.
49. Nithianantharajah J, Barkus C, Murphy M & Hannan AJ (2008). Gene-environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington's disease transgenic mice. Neurobiol Dis 29, 490-504.
50. Nithianantharajah J & Hannan AJ (2006). Enriched environments, experience-dependent plasticity and disorders of the nervous system. Nat Rev Neurosci 7, 697-709.
51. Ohno Y (2010). New insight into the therapeutic role of 5-HT1A receptors in central nervous system disorders. Cent Nerv Syst Agents Med Chem 10, 148-157.
52. Orvoen S, Pla P, Gardier AM, Saudou F & David DJ (2012). Huntington's disease knock-in male mice show specific anxiety-like behaviour and altered neuronal maturation. Neurosci Lett 507, 127-132.
53. Pang TY, Du X, Zajac MS, Howard ML & Hannan AJ (2009). Altered serotonin receptor expression is associated with depression-related behaviour in the R6/1 transgenic mouse model of Huntington's disease. Hum Mol Genet 18, 753-766.
54. Paulsen JS, Nehl C, Hoth KF, Kanz JE, Benjamin M, Conybeare R, McDowell B & Turner B (2005). Depression and stages of Huntington's disease. J Neuropsychiatry Clin Neurosci 17, 496-502.
55. Petersen A & Bjorkqvist M (2006). Hypothalamic-endocrine aspects in Huntington's disease. Eur J Neurosci 24, 961-967.
56. Qian J, Zhou D, Pan F, Liu CX & Wang YW (2008). Effect of environmental enrichment on fearful behaviour and gastrin-releasing peptide receptor expression in the amygdala of prenatal stressed rats. J Neurosci Res 86, 3011-3017.
57. Rasmuson S, Olsson T, Henriksson BG, Kelly PA, Holmes MC, Seckl JR & Mohammed AH (1998). Environmental enrichment selectively increases 5-HT1A receptor mRNA expression and binding in the rat hippocampus. Brain Res Mol Brain Res 53, 285-290.
58. Renard GM, Rivarola MA & Suarez MM (2007). Sexual dimorphism in rats: effects of early maternal separation and variable chronic stress on pituitary-adrenal axis and behaviour. Int J Dev Neurosci 25, 373-379.
59. Renoir T, Pang TY & Hannan AJ (2012a). Effects of environmental manipulations in genetically targeted animal models of affective disorders. Neurobiol Dis (in press).
60. Renoir T, Pang TY & Lanfumey L (2012b). Drug withdrawal-induced depression: serotonergic and plasticity changes in animal models. Neurosci Biobehav Rev 36, 696-726.
61. Renoir T, Pang TY, Zajac MS, Chan G, Du X, Leang L, Chevarin C, Lanfumey L & Hannan AJ (2012c). Treatment of depressive-like behaviour in Huntington's disease mice by chronic sertraline and exercise. Br J Pharmacol 165, 1375-1389.
62. Renoir T, Zajac MS, Du X, Pang TY, Leang L, Chevarin C, Lanfumey L & Hannan AJ (2011). Sexually dimorphic serotonergic dysfunction in a mouse model of Huntington's disease and depression. PLoS One 6, e22133.
63. Sales AJ, Biojone C, Terceti MS, Guimaraes FS, Gomes MV & Joca SR (2011). Antidepressant-like effect induced by systemic and intra-hippocampal administration of DNA methylation inhibitors. Br J Pharmacol 164, 1711-1721.
64. Soneson C, Fontes M, Zhou Y, Denisov V, Paulsen JS, Kirik D & Petersen A (2010). Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis. Neurobiol Dis 40, 531-543.
65. Suarez-Hitz KA, Otto B, Bidlingmaier M, Schwizer W, Fried M & Ehlert U (2012). Altered psychobiological responsiveness in women with irritable bowel syndrome. Psychosom Med 74, 221-231.
66. Sun H, Kennedy PJ & Nestler EJ (2012). Epigenetics of the depressed brain: role of histone acetylation and methylation. Neuropsychopharmacology [Epub ahead of print].
67. The Huntington's Disease Collaborative Research Group (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-983.
68. Thompson JC, Harris J, Sollom AC, Stopford CL, Howard E, Snowden JS & Craufurd D (2012). Longitudinal evaluation of neuropsychiatric symptoms in Huntington's disease. J Neuropsychiatry Clin Neurosci 24, 53-60.
69. Trembath MK, Horton ZA, Tippett L, Hogg V, Collins VR, Churchyard A, Velakoulis D, Roxburgh R & Delatycki MB (2010). A retrospective study of the impact of lifestyle on age at onset of Huntington disease. Mov Disord 25, 1444-1450.
70. van Dellen A, Blakemore C, Deacon R, York D & Hannan AJ (2000). Delaying the onset of Huntington's in mice. Nature 404, 721-722.
71. van der Burg JM, Winqvist A, Aziz NA, Maat-Schieman ML, Roos RA, Bates GP, Brundin P, Bjorkqvist M & Wierup N (2011). Gastrointestinal dysfunction contributes to weight loss in Huntington's disease mice. Neurobiol Dis 44, 1-8.
72. van Duijn E, Kingma EM, Timman R, Zitman FG, Tibben A, Roos RA & van der Mast RC (2008). Cross-sectional study on prevalences of psychiatric disorders in mutation carriers of Huntington's disease compared with mutation-negative first-degree relatives. J Clin Psychiatry 69, 1804-1810.
73. van Duijn E, Selis MA, Giltay EJ, Zitman FG, Roos RA, van Pelt H & van der Mast RC (2010). Hypothalamic-pituitary-adrenal axis functioning in Huntington's disease mutation carriers compared with mutation-negative first-degree controls. Brain Res Bull 83, 232-237.
74. Von Bohlen Und Halbach O (2010). Involvement of BDNF in age-dependent alterations in the hippocampus. Front Aging Neurosci 2.
75. Wolkowitz OM, Wolf J, Shelly W, Rosser R, Burke HM, Lerner GK, Reus VI, Nelson JC, Epel ES & Mellon SH (2011). Serum BDNF levels before treatment predict SSRI response in depression. Prog Neuropsychopharmacol Biol Psychiatry 35, 1623-1630.
76. Wood NI, Carta V, Milde S, Skillings EA, McAllister CJ, Ang YL, Duguid A, Wijesuriya N, Afzal SM, Fernandes JX, Leong TW & Morton AJ (2010). Responses to environmental enrichment differ with sex and genotype in a transgenic mouse model of Huntington's disease. PloS One 5, e9077.
77. Zajac MS, Pang TY, Wong N, Weinrich B, Leang LS, Craig JM, Saffery R & Hannan AJ (2010). Wheel running and environmental enrichment differentially modify exon-specific BDNF expression in the hippocampus of wild-type and pre-motor symptomatic male and female Huntington's disease mice. Hippocampus 20, 621-636.
78. Zhu X, Peng S, Zhang S & Zhang X (2011). Stress-induced depressive behaviors are correlated with Par-4 and DRD2 expression in rat striatum. Behav Brain Res 223, 329-335.
79. Zuccato C, Liber D, Ramos C, Tarditi A, Rigamonti D, Tartari M, Valenza M & Cattaneo E (2005). Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery. Pharmacol Res 52, 133-139.